Cargando…

Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy

Cancer immunotherapy has been a great breakthrough, with immune checkpoint inhibitors leading the way. Despite the clinical effectiveness of certain immune checkpoint inhibitors, the overall response rate remains low, and the effectiveness of immunotherapies for many tumors has been disappointing. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torphy, Robert J., Schulick, Richard D., Zhu, Yuwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751245/ https://www.ncbi.nlm.nih.gov/pubmed/29211042 http://dx.doi.org/10.3390/ijms18122642

Ejemplares similares

Immunotherapy for pancreatic cancer: Barriers and breakthroughs
por: Torphy, Robert J., et al.
Publicado: (2018)

Immune checkpoint therapy in liver cancer
por: Xu, Feng, et al.
Publicado: (2018)

Anaplastic Pancreatic Carcinoma Arising Within a Mucinous Cystic Neoplasm of the Pancreas: A Case Report and a Brief Review of the Literature
por: Paniccia, Alessandro, et al.
Publicado: (2017)

The GPR171 pathway suppresses T cell activation and limits antitumor immunity
por: Fujiwara, Yuki, et al.
Publicado: (2021)

Cancer Immunotherapy with Immune Checkpoint Inhibitors-Biomarkers of Response and Toxicity; Current Limitations and Future Promise
por: Healey Bird, Brian, et al.
Publicado: (2022)

Immune Checkpoints, Inhibitors and Radionuclides in Prostate Cancer: Promising Combinatorial Therapy Approach
por: Kgatle, Mankgopo M., et al.
Publicado: (2021)

GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models
por: Torphy, Robert J., et al.
Publicado: (2022)

Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?
por: Hosseinkhani, Negar, et al.
Publicado: (2020)

Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands
por: Kamali, Ali N., et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
por: Thomas, Remy, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients?
por: Musacchio, Lucia, et al.
Publicado: (2020)

Promising Strategy of mPTP Modulation in Cancer Therapy: An Emerging Progress and Future Insight
por: Waseem, Mohammad, et al.
Publicado: (2023)

The promising immune checkpoint LAG-3: from tumor microenvironment to cancer immunotherapy
por: Long, Long, et al.
Publicado: (2018)

BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment
por: Kone, Abdou-samad, et al.
Publicado: (2022)

Immune checkpoints represent a promising breakthrough in targeted therapy and prognosis of myelodysplastic syndrome
por: Guo, Xinyu, et al.
Publicado: (2023)

Immune Checkpoints as Promising Targets for the Treatment of Idiopathic Pulmonary Fibrosis?
por: Duitman, JanWillem, et al.
Publicado: (2019)

Immune Checkpoint in Glioblastoma: Promising and Challenging
por: Huang, Jing, et al.
Publicado: (2017)

Identification of CD112R as a novel checkpoint for human T cells
por: Zhu, Yuwen, et al.
Publicado: (2016)

Immune checkpoint therapy for pancreatic cancer
por: Johansson, Henrik, et al.
Publicado: (2016)

Development of immune checkpoint therapy for cancer
por: Fritz, Jill M., et al.
Publicado: (2019)

Immune Checkpoint Inhibitors in Cancer Therapy
por: Shiravand, Yavar, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects
por: Makaremi, Shima, et al.
Publicado: (2021)

Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer
por: Macherla, Shravanti, et al.
Publicado: (2018)

Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
por: Sun, Qian, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors Combined with Targeted Therapy: The Recent Advances and Future Potentials
por: Li, Bin, et al.
Publicado: (2023)

Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks
por: Fanciulli, Giuseppe, et al.
Publicado: (2020)

Immune checkpoint inhibitors in cancer therapy
por: Webb, Eika S., et al.
Publicado: (2018)

Immune Checkpoint Inhibitors: A Promising Treatment Option for Metastatic Castration-Resistant Prostate Cancer?
por: Ruiz de Porras, Vicenç, et al.
Publicado: (2021)

Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
por: Lee, Juwon, et al.
Publicado: (2021)

The Role of Immune Checkpoint Inhibitors in Cancer Therapy
por: Basudan, Ahmed M.
Publicado: (2022)

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook
por: Gopalakrishnan, Dharmesh, et al.
Publicado: (2018)

Emerging Immune-Monitoring System for Immune Checkpoint Inhibitors
por: Hamada, Kazuyuki, et al.
Publicado: (2022)

Transcriptional Regulation of Cancer Immune Checkpoints: Emerging Strategies for Immunotherapy
por: Venkatraman, Simran, et al.
Publicado: (2020)

Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option
por: Ren, Yi, et al.
Publicado: (2022)

IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy
por: Tang, Xi-Yang, et al.
Publicado: (2022)

Future of immune checkpoint inhibitors: focus on tumor immune microenvironment
por: Jia, Yunlong, et al.
Publicado: (2020)

Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer
por: Qiu, Zhenbin, et al.
Publicado: (2019)

Immune Checkpoint Inhibitors in the Treatment of Renal Cancer: Current State and Future Perspective
por: Lavacchi, Daniele, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives
por: Borella, Fulvio, et al.
Publicado: (2020)

Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer
por: Seesaha, Poshita-Kumari, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qh6fhdpom1ceqajvmefr3fkefh